{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:14:34Z","timestamp":1790306074735,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1007\/s00277-002-0597-6","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T10:27:58Z","timestamp":1516098478000},"page":"69-76","source":"Crossref","is-referenced-by-count":47,"title":["Malignant thymoma: current status of classification and multimodality treatment"],"prefix":"10.1007","volume":"82","author":[{"given":"I. G. H.","family":"Schmidt-Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. K.","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sch\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hirner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Grohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. K.","family":"M\u00fcller-Hermelink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Huhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,2,11]]},"reference":[{"key":"597_CR1","first-page":"46","volume":"36","author":"Agrawal","year":"1999","unstructured":"Agrawal S, Datta NR, Mishra SK, Kumar S, Tandon V, Ayyagari S, Agarwal A (1999) Adjuvant therapy in invasive thymoma: an audit of cases treated over an 8\u00a0year period. Indian J Cancer 36:46\u201356","journal-title":"Indian J Cancer"},{"key":"597_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/(SICI)1096-9098(199609)63:1<17::AID-JSO4>3.0.CO;2-T","volume":"63","author":"Akaogi","year":"1996","unstructured":"Akaogi E, Ohara K, Mitsui K, Onizuka M, Ishikawa S, Mitsui T, Ogata T (1996) Preoperative radiotherapy and surgery for advanced thymoma with invasion to the great vessels. J Surg Oncol 63:17\u201322","journal-title":"J Surg Oncol"},{"key":"597_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0360-3016(79)90042-7","volume":"5","author":"Ariaratnam","year":"1979","unstructured":"Ariaratnam LS, Kalnicki S, Mincer F, Botstein C (1979) The management of malignant thymoma with radiation therapy. Int J Radiat Oncol Biol Phys 5:77\u201380","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"597_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0039-6109(16)40093-9","volume":"53","author":"Bernatz","year":"1973","unstructured":"Bernatz PE, Khonsari S, Harrison EG, Jr., Taylor WF (1973) Thymoma: factors influencing prognosis. Surg Clin North Am 53:885\u2013892","journal-title":"Surg Clin North Am"},{"key":"597_CR5","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/0140-6736(90)91415-7","volume":"335","author":"Berthaud","year":"1990","unstructured":"Berthaud P, Le Chevalier T, Tursz T (1990) Effectiveness of interleukin-2 in invasive lymphoepithelial thymoma. Lancet 335:1590","journal-title":"Lancet"},{"key":"597_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/00000421-199308000-00014","volume":"16","author":"Bonomi","year":"1993","unstructured":"Bonomi PD, Finkelstein D, Aisner S, Ettinger D (1993) EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol 16:342\u2013345","journal-title":"Am J Clin Oncol"},{"key":"597_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/00000421-200004000-00007","volume":"23","author":"Bott-Kothari","year":"2000","unstructured":"Bott-Kothari T, Aron BS, Bejarano P (2000) Malignant thymoma with metastases to the gastrointestinal tract and ovary: a case report and literature review. Am J Clin Oncol 23:140\u2013142","journal-title":"Am J Clin Oncol"},{"key":"597_CR8","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1212\/WNL.57.9.1579","volume":"57","author":"Buckley","year":"2001","unstructured":"Buckley C, Newsom-Davis J, Willcox N, Vincent A (2001) Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence? Neurology 57:1579\u20131582","journal-title":"Neurology"},{"key":"597_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/sj.cgt.7700323","volume":"8","author":"Buttgereit","year":"2001","unstructured":"Buttgereit P, Schakowski F, Marten A, Brand K, Renoth S, Ziske C, Schottker B, Ebert O, Schroers R, Schmidt-Wolf IG (2001) Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells. Cancer Gene Ther 8:430\u2013439","journal-title":"Cancer Gene Ther"},{"key":"597_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/cncr.10665","volume":"95","author":"Chen","year":"2002","unstructured":"Chen G, Marx A, Wen-Hu C, Yong J, Puppe B, Stroebel P, Mueller-Hermelink HK (2002) New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 95:420\u2013429","journal-title":"Cancer"},{"key":"597_CR11","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1200\/JCO.1994.12.7.1484","volume":"12","author":"Ciernik","year":"1994","unstructured":"Ciernik IF, Meier U, Lutolf UM (1994) Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 12:1484\u20131490","journal-title":"J Clin Oncol"},{"key":"597_CR12","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1200\/JCO.1988.6.11.1722","volume":"6","author":"Curran","year":"1988","unstructured":"Curran WJ, Jr., Kornstein MJ, Brooks JJ, Turrisi AT, 3rd (1988) Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6:1722\u20131727","journal-title":"J Clin Oncol"},{"key":"597_CR13","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/1097-0142(19801001)46:7<1523::AID-CNCR2820460705>3.0.CO;2-#","volume":"46","author":"Evans","year":"1980","unstructured":"Evans WK, Thompson DM, Simpson WJ, Feld R, Phillips MJ (1980) Combination chemotherapy in invasive thymoma role of COPP. Cancer 46:1523\u20131527","journal-title":"Cancer"},{"key":"597_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4","volume":"68","author":"Fornasiero","year":"1991","unstructured":"Fornasiero A, Daniele O, Ghiotto C, Piazza M, Fiore-Donati L, Calabro F, Rea F, Fiorentino MV (1991) Chemotherapy for invasive thymoma. A 13-year experience. Cancer 68:30\u201333","journal-title":"Cancer"},{"key":"597_CR15","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/JCO.1990.8.8.1419","volume":"8","author":"Fornasiero","year":"1990","unstructured":"Fornasiero DO, Ghiotto C, Sartori F, Rea F, Piazza M, Fiore-Donati L, Morandi P, Aversa SM, Paccagnella A, et al. (1990) Chemotherapy of invasive thymoma. J Clin Oncol 8:1419\u20131423","journal-title":"J Clin Oncol"},{"key":"597_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","volume":"14","author":"Giaccone","year":"1996","unstructured":"Giaccone G, Ardizzoni A, Kirkpatrick A, Clerico M, Sahmoud T, van Zandwijk N (1996) Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 14:814\u2013820","journal-title":"J Clin Oncol"},{"key":"597_CR17","first-page":"695","volume":"69","author":"Giaccone","year":"1985","unstructured":"Giaccone G, Musella R, Bertetto O, Donadio M, Calciati A (1985) Cisplatin-containing chemotherapy in the treatment of invasive thymoma: report of five cases. Cancer Treat Rep 69:695\u2013697","journal-title":"Cancer Treat Rep"},{"key":"597_CR18","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/1097-0142(19890415)63:8<1493::AID-CNCR2820630807>3.0.CO;2-C","volume":"63","author":"Goldel","year":"1989","unstructured":"Goldel N, Boning L, Fredrik A, Holzel D, Hartenstein R, Wilmanns W (1989) Chemotherapy of invasive thymoma. A retrospective study of 22 cases. Cancer 63:1493\u20131500","journal-title":"Cancer"},{"key":"597_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00002371-199510000-00005","volume":"18","author":"Gordon","year":"1995","unstructured":"Gordon MS, Battiato LA, Gonin R, Harrison-Mann BC, Loehrer PJ Sr (1995) A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed\/refractory thymoma. J Immunother 18:179\u2013184","journal-title":"J Immunother"},{"key":"597_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/stcs.2000.17955","volume":"12","author":"Graeber","year":"2000","unstructured":"Graeber GM, Tamim W (2000) Current status of the diagnosis and treatment of thymoma. Semin Thorac Cardiovasc Surg 12:268\u2013277","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"597_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0003-4975(92)91391-L","volume":"54","author":"Haniuda","year":"1992","unstructured":"Haniuda M, Morimoto M, Nishimura H, Kobayashi O, Yamanda T, Iida F (1992) Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Surg 54:311\u2013315","journal-title":"Ann Thorac Surg"},{"key":"597_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/sj.bmt.1703181","volume":"28","author":"Hanna","year":"2001","unstructured":"Hanna N, Gharpure VS, Abonour R, Cornetta K, Loehrer PJ Sr (2001) High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience. Bone Marrow Transplant 28:435\u2013438","journal-title":"Bone Marrow Transplant"},{"key":"597_CR23","first-page":"300","volume":"10","author":"Harper","year":"1991","unstructured":"Harper HM, Rankin E, et al. (1991) Ifosfamide monotherapy demonstrates high activity in malignant thymoma. Proc ASCO 10:300","journal-title":"Proc ASCO"},{"key":"597_CR24","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1200\/JCO.1999.17.9.2737","volume":"17","author":"Highley","year":"1999","unstructured":"Highley MS, Underhill CR, Parnis FX, Karapetis C, Rankin E, Dussek J, Bryant B, Rowland C, Hodson N, Hughes J, Harper PG (1999) Treatment of invasive thymoma with single-agent ifosfamide. J Clin Oncol 17:2737\u20132744","journal-title":"J Clin Oncol"},{"key":"597_CR25","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood.V96.12.3872","volume":"96","author":"Hoffacker","year":"2000","unstructured":"Hoffacker V, Schultz A, Tiesinga JJ, Gold R, Schalke B, Nix W, Kiefer R, Muller-Hermelink HK, Marx A (2000) Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood 96:3872\u20133879","journal-title":"Blood"},{"key":"597_CR26","unstructured":"Huhn D (2000) Thymuskarzinom und Thymom. In: Wilmanns W, Huhn D, Wilms K (eds) Internistische Onkologie. Georg Thieme, Stuttgart, pp 641\u2013642"},{"key":"597_CR27","first-page":"288","volume":"36","author":"Iwasaki","year":"1998","unstructured":"Iwasaki Y, Kubota Y, Yokomura I, Ueda M, Hashimoto S, Arimoto T, Inaba T, Shimazaki C, Nakagawa M, Toda S (1998) Invasive thymoma successfully treated with high-dose chemotherapy followed by peripheral blood stem cell transplantation (PBSCT) (in Japanese). Nihon Kokyuki Gakkai Zasshi 36:288\u2013293","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"597_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0167-8140(91)90078-U","volume":"21","author":"Jackson","year":"1991","unstructured":"Jackson MA, Ball DL (1991) Post-operative radiotherapy in invasive thymoma. Radiother Oncol 21:77\u201382","journal-title":"Radiother Oncol"},{"key":"597_CR29","first-page":"1948","volume":"61","author":"Kanwar","year":"2001","unstructured":"Kanwar JR, Kanwar RK, Pandey S, Ching LM, Krissansen GW (2001) Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci. Cancer Res 61:1948\u20131956","journal-title":"Cancer Res"},{"key":"597_CR30","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1097\/00000478-199212000-00003","volume":"16","author":"Kirchner","year":"1992","unstructured":"Kirchner T, Schalke B, Buchwald J, Ritter M, Marx A, Muller-Hermelink HK (1992) Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol 16:1153\u20131169","journal-title":"Am J Surg Pathol"},{"key":"597_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","volume":"44","author":"Koga","year":"1994","unstructured":"Koga K, Matsuno Y, Noguchi M, Mukai K, Asamura H, Goya T, Shimosato Y (1994) A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 44:359\u2013367","journal-title":"Pathol Int"},{"key":"597_CR32","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/1097-0142(19880501)61:9<1736::AID-CNCR2820610903>3.0.CO;2-T","volume":"61","author":"Kosmidis","year":"1988","unstructured":"Kosmidis PA, Iliopoulos E, Pentea S (1988) Combination chemotherapy with cyclophosphamide, adriamycin, and vincristine in malignant thymoma and myasthenia gravis. Cancer 61:1736\u20131740","journal-title":"Cancer"},{"key":"597_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1053\/ctrv.1999.0159","volume":"26","author":"Lara","year":"2000","unstructured":"Lara PN Jr (2000) Malignant thymoma: current status and future directions. Cancer Treat Rev 26:127\u2013131","journal-title":"Cancer Treat Rev"},{"key":"597_CR34","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/1097-0142(196211\/12)15:6<1224::AID-CNCR2820150621>3.0.CO;2-V","volume":"15","author":"Lattes","year":"1962","unstructured":"Lattes (1962) Thymoma and other tumors of the thymus. An analysis of 107 cases. Cancer 15:1224\u20131260","journal-title":"Cancer"},{"key":"597_CR35","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1148\/radiology.204.3.9280272","volume":"204","author":"Latz","year":"1997","unstructured":"Latz D, Schraube P, Oppitz U, Kugler C, Manegold C, Flentje M, Wannenmacher MF (1997) Invasive thymoma: treatment with postoperative radiation therapy. Radiology 204:859\u2013864","journal-title":"Radiology"},{"key":"597_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0046-8177(78)80131-2","volume":"9","author":"Levine","year":"1978","unstructured":"Levine GD, Rosai J (1978) Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol 9:495\u2013515","journal-title":"Hum Pathol"},{"key":"597_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0049-0172(98)80039-5","volume":"28","author":"Levy","year":"1998","unstructured":"Levy Y, Afek A, Sherer Y, Bar-Dayan Y, Shibi R, Kopolovic J, Shoenfeld Y (1998) Malignant thymoma associated with autoimmune diseases: a retrospective study and review of the literature. Semin Arthritis Rheum 28:73\u201379","journal-title":"Semin Arthritis Rheum"},{"key":"597_CR38","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJM198505163122006","volume":"312","author":"Leyvraz","year":"1985","unstructured":"Leyvraz S, Henle W, Chahinian AP, Perlmann C, Klein G, Gordon RE, Rosenblum M, Holland JF (1985) Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 312:1296\u20131299","journal-title":"N Engl J Med"},{"key":"597_CR39","first-page":"73","volume":"31","author":"Loehrer","year":"1999","unstructured":"Loehrer PJ Sr (1999) Current approaches to the treatment of thymoma. Ann Med 31:73\u201379","journal-title":"Ann Med"},{"key":"597_CR40","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","volume":"15","author":"Loehrer","year":"1997","unstructured":"Loehrer PJ Sr, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, Johnson D (1997) Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol 15:3093\u20133099","journal-title":"J Clin Oncol"},{"key":"597_CR41","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","volume":"12","author":"Loehrer","year":"1994","unstructured":"Loehrer PJ Sr, Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, Blum R (1994) Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 12:1164\u20131168","journal-title":"J Clin Oncol"},{"key":"597_CR42","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1053\/ejso.2001.1197","volume":"27","author":"Lucchi","year":"2001","unstructured":"Lucchi M, Mussi A, Ambrogi M, Gunfiotti A, Fontanini G, Basolo F, Angeletti CA (2001) Thymic carcinoma: a report of 13 cases. Eur J Surg Oncol 27:636\u2013640","journal-title":"Eur J Surg Oncol"},{"key":"597_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/1097-0142(19910815)68:4<706::AID-CNCR2820680407>3.0.CO;2-H","volume":"68","author":"Macchiarini","year":"1991","unstructured":"Macchiarini P, Chella A, Ducci F, Rossi B, Testi C, Bevilacqua G, Angeletti CA (1991) Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 68:706\u2013713","journal-title":"Cancer"},{"key":"597_CR44","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0003-4975(91)90478-9","volume":"51","author":"Maggi","year":"1991","unstructured":"Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E (1991) Thymoma: results of 241 operated cases. Ann Thorac Surg 51:152\u2013156","journal-title":"Ann Thorac Surg"},{"key":"597_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF00737071","volume":"407","author":"Marino","year":"1985","unstructured":"Marino M, Muller-Hermelink HK (1985) Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch 407:119\u2013149","journal-title":"Virchows Arch"},{"key":"597_CR46","unstructured":"McKenna BP, Barnes MM, Glatstein E, Rucksdeshel JC, Weisenburger TH (1989) Malignancies of the thymus. In: Rucksdeshel JC, Weisenburger TH (eds) Thoracic oncology. WB Saunders, Philadelphia, pp 466\u2013477"},{"key":"597_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0003-4975(10)62558-1","volume":"39","author":"Monden","year":"1985","unstructured":"Monden Y, Nakahara K, Iioka S, Nanjo S, Ohno K, Fujii Y, Hashimoto J, Kitagawa Y, Masaoka A, Kawashima Y (1985) Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg 39:165\u2013169","journal-title":"Ann Thorac Surg"},{"key":"597_CR48","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0360-3016(95)00079-E","volume":"32","author":"Mornex","year":"1995","unstructured":"Mornex F, Resbeut M, Richaud P, Jung GM, Mirabel X, Marchal C, Lagrange JL, Rambert P, Chaplain G, Nguyen TD (1995) Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Int J Radiat Oncol Biol Phys 32:651\u2013659","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"597_CR49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-3-642-82480-7_7","volume":"75","author":"Muller-Hermelink","year":"1986","unstructured":"Muller-Hermelink HK, Marino M, Palestro G (1986) Pathology of thymic epithelial tumors. Curr Top Pathol 75:207\u2013268","journal-title":"Curr Top Pathol"},{"key":"597_CR50","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/00001622-200009000-00007","volume":"12","author":"Muller-Hermelink","year":"2000","unstructured":"Muller-Hermelink HK, Marx A (2000) Thymoma. Curr Opin Oncol 12: 426\u2013433","journal-title":"Curr Opin Oncol"},{"key":"597_CR51","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1046\/j.1365-2559.2000.00860.x","volume":"36","author":"Muller-Hermelink","year":"2000","unstructured":"Muller-Hermelink HK, Marx A (2000) Towards a histogenetic classification of thymic epithelial tumours? Histopathology 36:466\u2013469","journal-title":"Histopathology"},{"key":"597_CR52","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0360-3016(99)00514-3","volume":"46","author":"Myojin","year":"2000","unstructured":"Myojin M, Choi NC, Wright CD, Wain JC, Harris N, Hug EB, Mathisen DJ, Lynch T, Carey RW, Grossbard M, Finkelstein DM, Grillo HC (2000) Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys 46:927\u2013933","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"597_CR53","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/cncr.10226","volume":"94","author":"Okumura","year":"2002","unstructured":"Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H, Masaoka A (2002) The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94:624\u2013632","journal-title":"Cancer"},{"key":"597_CR54","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/cncr.10374","volume":"94","author":"Palmieri","year":"2002","unstructured":"Palmieri G, Montella L, Martignetti A, Muto P, Di Vizio D, De Chiara A, Lastoria S (2002) Somatostatin analogs and prednisone in advanced refractory thymic tumors. Cancer 94:1414\u20131420","journal-title":"Cancer"},{"key":"597_CR55","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00000478-200101000-00013","volume":"25","author":"Pan","year":"2001","unstructured":"Pan CC, Chen WY, Chiang H (2001) Spindle cell and mixed spindle\/lymphocytic thymomas: an integrated clinicopathologic and immunohistochemical study of 81 cases. Am J Surg Pathol 25:111\u2013120","journal-title":"Am J Surg Pathol"},{"key":"597_CR56","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1002\/1097-0142(19940515)73:10<2491::AID-CNCR2820731007>3.0.CO;2-6","volume":"73","author":"Park","year":"1994","unstructured":"Park HS, Shin DM, Lee JS, Komaki R, Pollack A, Putnam JB, Cox JD, Hong WK (1994) Thymoma. A retrospective study of 87 cases. Cancer 73:2491\u20132498","journal-title":"Cancer"},{"key":"597_CR57","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/bjs.1800590708","volume":"59","author":"Penn","year":"1972","unstructured":"Penn CR, Hope-Stone HF (1972) The role of radiotherapy in the management of malignant thymoma. Br J Surg 59:533\u2013539","journal-title":"Br J Surg"},{"key":"597_CR58","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-5223(19)34092-9","volume":"106","author":"Rea","year":"1993","unstructured":"Rea F, Sartori F, Loy M, Calabro F, Fornasiero A, Daniele O, Altavilla G (1993) Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 106:543\u2013549","journal-title":"J Thorac Cardiovasc Surg"},{"key":"597_CR59","first-page":"18","volume":"16","author":"Ritter","year":"1999","unstructured":"Ritter JH, Wick MR (1999) Primary carcinomas of the thymus gland. Semin Diagn Pathol 16:18\u201331","journal-title":"Semin Diagn Pathol"},{"key":"597_CR60","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1001\/archneur.57.11.1596","volume":"57","author":"Romi","year":"2000","unstructured":"Romi F SG, Aarli JA, Geilhus NE (2000) The severity of myasthenia gravis correlated with the serum concentration of titin and ryanodine receptor autoantibodies. Arch Neurol 57:1596\u20131600","journal-title":"Arch Neurol"},{"key":"597_CR61","doi-asserted-by":"crossref","unstructured":"Rosai (ed) (1999) Histological typing of tumors of the thymus. Springer, Berlin Heidelberg New York","DOI":"10.1007\/978-3-642-60157-6"},{"key":"597_CR62","unstructured":"Rosenberg SA (1992) Thymic neoplasms. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer principles and practice of oncology. Lippincott, Philadelphia, pp 763\u2013770"},{"key":"597_CR63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.1365-2141.2002.03365.x","volume":"117","author":"Schmidt-Wolf","year":"2002","unstructured":"Schmidt-Wolf G, Schmidt-Wolf IGH (2002) Immunomodulatory gene therapy for haematological malignancies. Br J Haematol 117:23\u201332","journal-title":"Br J Haematol"},{"key":"597_CR64","doi-asserted-by":"crossref","unstructured":"Sch\u00fctte J (1995) Thymome. In: Seeber S, Sch\u00fctte J (eds) Therapiekonzepte Onkologie. Springer, Berlin Heidelberg New York, pp 488\u2013499","DOI":"10.1007\/978-3-662-10494-1_20"},{"key":"597_CR65","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/ana.410280303","volume":"28","author":"Sommer","year":"1990","unstructured":"Sommer N, Willcox N, Harcourt GC, Newsom-Davis J (1990) Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann Neurol 28:312\u2013319","journal-title":"Ann Neurol"},{"key":"597_CR66","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/archinte.1974.00320200184029","volume":"134","author":"Souadjian","year":"1974","unstructured":"Souadjian JV, Enriquez P, Silverstein MN, Pepin JM (1974) The spectrum of diseases associated with thymoma. Coincidence or syndrome? Arch Intern Med 134:374\u2013379","journal-title":"Arch Intern Med"},{"key":"597_CR67","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood.V100.1.159","volume":"100","author":"Strobel","year":"2002","unstructured":"Strobel P, Helmreich M, Menioudakis G, Lewin SR, Rudiger T, Bauer A, Hoffacker V, Gold R, Nix W, Schalke B, Elert O, Semik M, Muller-Hermelink HK, Marx A (2002) Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas. Blood 100:159\u2013166","journal-title":"Blood"},{"key":"597_CR68","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/00005382-199907000-00002","volume":"14","author":"Strollo","year":"1999","unstructured":"Strollo DC, Rosado-de-Christenson ML (1999) Tumors of the thymus. J Thorac Imaging 14:152\u2013171","journal-title":"J Thorac Imaging"},{"key":"597_CR69","first-page":"2","volume":"16","author":"Suster","year":"1999","unstructured":"Suster S, Moran CA (1999) Primary thymic epithelial neoplasms: spectrum of differentiation and histological features. Semin Diagn Pathol 16:2\u201317","journal-title":"Semin Diagn Pathol"},{"key":"597_CR70","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/ajcp\/111.6.826","volume":"111","author":"Suster","year":"1999","unstructured":"Suster S, Moran CA (1999) Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms. Am J Clin Pathol 111:826\u2013833","journal-title":"Am J Clin Pathol"},{"key":"597_CR71","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/BF03218184","volume":"48","author":"Takahashi","year":"2000","unstructured":"Takahashi K, Yoshida J, Nishimura M, Nagai K (2000) Thymic carcinoma. Outcome of treatment including surgical resection. Jpn J Thorac Cardiovasc Surg 48:494\u2013498","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"597_CR72","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1200\/JCO.1999.17.7.2280","volume":"17","author":"Thomas","year":"1999","unstructured":"Thomas CR, Wright CD, Loehrer PJ (1999) Thymoma: state of the art. J Clin Oncol 17:2280\u20132289","journal-title":"J Clin Oncol"},{"key":"597_CR73","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0167-8140(92)90227-L","volume":"24","author":"Urgesi","year":"1992","unstructured":"Urgesi A, Monetti U, Rossi G, Ricardi U, Maggi G, Sannazzari GL (1992) Aggressive treatment of intrathoracic recurrences of thymoma. Radiother Oncol 24:221\u2013225","journal-title":"Radiother Oncol"},{"key":"597_CR74","doi-asserted-by":"publisher","first-page":"869","DOI":"10.4049\/jimmunol.165.2.869","volume":"165","author":"van","year":"2000","unstructured":"van Hall T, van Bergen J, van Veelen PA, Kraakman M, Heukamp LC, Koning F, Melief CJ, Ossendorp F, Offringa R (2000) Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin. J Immunol 165:869\u2013877","journal-title":"J Immunol"},{"key":"597_CR75","first-page":"3","volume":"19","author":"Whooley","year":"2000","unstructured":"Whooley BP, Urschel JD, Antkowiak JG, Takita H (2000) A 25-year thymoma treatment review. J Exp Clin Cancer Res 19:3\u20135","journal-title":"J Exp Clin Cancer Res"},{"key":"597_CR76","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/archneur.58.6.885","volume":"59","author":"Yamamoto","year":"2001","unstructured":"Yamamoto AM GP, Eymard B, Tranchant C, Warter JM, Gomez L, Bourquin C, Bach JF, Garchon HJ (2001) Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol 59:885\u2013890","journal-title":"Arch Neurol"},{"key":"597_CR77","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0002-9440(10)64536-1","volume":"157","author":"Zettl","year":"2000","unstructured":"Zettl A, Strobel P, Wagner K, Katzenberger T, Ott G, Rosenwald A, Peters K, Krein A, Semik M, Muller-Hermelink HK, Marx A (2000) Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol 157:257\u2013266","journal-title":"Am J Pathol"},{"key":"597_CR78","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0002-9440(10)63031-3","volume":"159","author":"Zhou","year":"2001","unstructured":"Zhou R, Zettl A, Strobel P, Wagner K, Muller-Hermelink HK, Zhang S, Marx A, Starostik P (2001) Thymic epithelial tumors can develop along two different pathogenetic pathways. Am J Pathol 159:1853\u20131860","journal-title":"Am J Pathol"},{"key":"597_CR79","unstructured":"DeVita VT, Hellman S, Rosenberg SA (eds) (1993) Cancer principles and practice of oncology, 4th edn. Lippincott, Philadelphia, pp 763\u2013770"},{"key":"597_CR80","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"Masaoka","year":"1981","unstructured":"Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485\u20132492","journal-title":"Cancer"},{"key":"597_CR81","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/oxfordjournals.annonc.a058527","volume":"4","author":"Berruti","year":"1993","unstructured":"Berruti A, Borasio P, Roncari A, Gorzegno G, Mossetti C, Dogliotti L (1993) Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients. Ann Oncol 4:429\u2013431","journal-title":"Ann Oncol"},{"key":"597_CR82","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1200\/JCO.1988.6.3.536","volume":"6","author":"Dy","year":"1988","unstructured":"Dy C, Calvo FA, Mondan JP, Aparicio LA, Algarra SM, Gil A, Gonzalez F, Harguindey S (1988) Undifferentiated epithelial-rich invasive malignant thymoma: complete response to cisplatin, vinblastine, and bleomycin therapy. J Clin Oncol 6:536\u2013542","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-002-0597-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-002-0597-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-002-0597-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-002-0597-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T17:39:43Z","timestamp":1603647583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-002-0597-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1007\/s00277-002-0597-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}